DISPERSYN GERRIT (Chief Development Officer) purchased 2.2% of their position (1.95K shares) of PHIO PHARMACEUTICALS CORP. on the open market
Open‑market purchase worth $5.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/5/2021ACC: 0001209191-21-018054
Officer· Chief Development Officer
Since Aug 2018
+1.95K
Net shares
Net buyer
$5.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
1.95K acquired
Non-Derivative Transactions1
Common stock, $0.0001 par value
Direct
Shares
+1.95K
Price / share
$2.56
Trade value
$5K
% of position
2.2%
3/4/2021
87.33K→89.28K
Total
Net shares
+1.95K
Net value
$5K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, $0.0001 par value Direct | 3/4/2021 | P · Purchase | +1.95K | $2.56 | $5K | 2.2% | 87.33K | 89.28K |
| Total | +1.95K | $5K | ||||||
Derivative Transactions0
No derivative transactions reported